DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Hepatitis C Virus (Emerging Market Special Report) | Emerging Markets | China | 2015
Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma in China. The prevalence of this chronic disease remains high owing to the presence of a large…
Novel Classes of Biologics vs. TNF-Alpha Inhibitors for Crohn’s Disease and Ulcerative Colitis | Physician & Payer Forum | US | 2015
Crohn’s disease (CD) and ulcerative colitis (UC) are the two gastrointestinal inflammatory disorders that constitute inflammatory bowel disease (IBD), affecting approximately 1.25 million people…